Recruiting Alopecia Studies in Fort Smith
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the bod...
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
This study will evaluate the safety and efficacy of VDPHL01 in female subjects with Androgenetic Alopecia (AGA). AGA is a genetic disorder caused by an excessive (too much) hair follicle response to ...
About Alopecia Clinical Trials in Fort Smith
Alopecia refers to hair loss from any part of the body, with alopecia areata being an autoimmune form causing patchy hair loss. It can range from small patches to total body hair loss. Treatments include JAK inhibitors, corticosteroids, and immunotherapy.
There are currently 2 alopecia clinical trials recruiting participants in Fort Smith, AR. These studies are seeking a combined 2,052 participants. Research is being sponsored by AbbVie, Veradermics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Alopecia Clinical Trials in Fort Smith — FAQ
Are there alopecia clinical trials in Fort Smith?
Yes, there are 2 alopecia clinical trials currently recruiting in Fort Smith, AR. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fort Smith?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fort Smith research site will contact you about next steps.
Are clinical trials in Fort Smith free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fort Smith studies also compensate for your time and travel.
What alopecia treatments are being tested?
The 2 active trials in Fort Smith are testing new therapies including novel drugs, biologics, and treatment approaches for alopecia.
Data updated March 2, 2026 from ClinicalTrials.gov